Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

227
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
227
Pneumothorax-II01:27

Pneumothorax-II

153
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
153

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigation of Donor-Transmitted Strongyloides stercoralis Infections in Solid Organ Transplant Recipients, United States, 2012-2024.

Emerging infectious diseases·2026
Same author

Food insecurity in New York City college students during the COVID-19 pandemic: a longitudinal analysis of predictors, correlates, and trajectories.

Journal of American college health : J of ACH·2026
Same author

Assessing current capabilities and barriers to performing routine laboratory tests on patients with suspected high consequence infectious disease at frontline acute care hospitals.

Infection control and hospital epidemiology·2026
Same author

Patient Information, Motivations, and Behavioral Skills during Early Implementation of Doxy-PEP in New York City.

Sexually transmitted diseases·2026
Same author

A Randomized Controlled Trial of a Digital Patient Decision Tool to Increase Sexually Transmitted Infection Testing in the Emergency Department.

Annals of emergency medicine·2026
Same author

CROI 2026: Tuberculosis and Other Infectious Complications in People With HIV.

Topics in antiviral medicine·2026
Same journal

Severe Postoperative Hypernatremia in an Adolescent Following Sleeve Gastrectomy.

Pediatrics·2026
Same journal

Barriers to Implementing SMART for Asthma in Pediatric Primary Care.

Pediatrics·2026
Same journal

Blood Lead Testing Among Children Enrolled in Medicaid.

Pediatrics·2026
Same journal

From Screening to Support: Crafting Social Needs Response Systems That Work for Families.

Pediatrics·2026
Same journal

A Social Care Intervention in Pediatric Practices: A Stepped Wedge Cluster Trial.

Pediatrics·2026
Same journal

Pediatric Cheerleading-Related Head Injuries and the "Double Down" Rule Change.

Pediatrics·2026
See all related articles

Related Experiment Video

Updated: Jul 5, 2025

Author Spotlight: Exploring Venous Waveforms in Porcine Models to Tackle Volume Overload in Medicine
06:09

Author Spotlight: Exploring Venous Waveforms in Porcine Models to Tackle Volume Overload in Medicine

Published on: January 12, 2024

612

Mpox in Children: 3 Cases.

Irene Frantzis1, Stephanie P Ungar2, Vijaya L Soma2

  • 1Departments of Pediatrics.

Pediatrics
|January 19, 2024
PubMed
Summary
This summary is machine-generated.

The 2022 mpox outbreak impacted children, with three New York City pediatric cases showing varied symptoms and transmission routes. All three children recovered after treatment with tecovirimat, an antiviral medication, without adverse effects.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K
Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
04:55

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children

Published on: September 11, 2018

10.8K

Related Experiment Videos

Last Updated: Jul 5, 2025

Author Spotlight: Exploring Venous Waveforms in Porcine Models to Tackle Volume Overload in Medicine
06:09

Author Spotlight: Exploring Venous Waveforms in Porcine Models to Tackle Volume Overload in Medicine

Published on: January 12, 2024

612
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K
Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
04:55

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children

Published on: September 11, 2018

10.8K

Area of Science:

  • Pediatric Infectious Diseases
  • Viral Outbreak Epidemiology
  • Clinical Case Studies

Background:

  • The 2022 mpox outbreak primarily affected adults, but substantial impact on children and adolescents was also observed.
  • Limited data exists on mpox clinical presentation and management in pediatric populations, particularly outside endemic regions.

Purpose of the Study:

  • To describe the clinical course and treatment of the first three pediatric mpox cases in New York City.
  • To highlight unique transmission routes, clinical presentations, and diagnostic challenges in children compared to previous reports.

Main Methods:

  • Retrospective case series describing three pediatric patients diagnosed with mpox.
  • Review of clinical data, including transmission, symptoms, diagnosis, and treatment with tecovirimat.

Main Results:

  • The three pediatric cases presented with varied clinical manifestations and transmission routes, differing from established mpox profiles.
  • All patients received tecovirimat treatment under an FDA expanded access investigational new drug application.
  • Complete recovery was observed in all three children without any adverse reactions to the antiviral treatment.

Conclusions:

  • Pediatric mpox cases can exhibit distinct clinical features and transmission dynamics.
  • Tecovirimat appears to be a safe and effective treatment option for mpox in children, warranting further investigation.